12/20/2024
5:25 PM | Janux Therapeutics (Issuer)
Meyer Andrew Hollman (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
3:32 PM | Janux Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
3:28 PM | Janux Therapeutics (Filer)
| Form 424B5 | |
12/03/2024
7:00 PM | Campbell David Alan (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
4:10 PM | Janux Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2024
7:00 PM | Campbell David Alan (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
3:24 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Janux Therapeutics (Subject)
| Form SC 13G/A | |
|
11/08/2024
4:58 PM | Avalon Ventures XI, L.P. (Filed by)
Janux Therapeutics (Subject)
| Form SC 13D/A | |
11/07/2024
6:08 PM | CAPPS VICKIE L (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/07/2024
6:09 PM | Gujrathi Sheila (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
3:23 PM | Janux Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
3:07 PM | Janux Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
4:05 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
4:02 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:24 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:30 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:17 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2024
3:07 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/30/2024
6:30 PM | Campbell David Alan (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/28/2024
3:46 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024
4:28 PM | Avalon Ventures XI, L.P. (Filed by)
Janux Therapeutics (Subject)
| Form SC 13D/A | |
10/25/2024
3:57 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024
3:44 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024
3:51 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/25/2024
11:37 AM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144/A | |
10/24/2024
4:53 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/24/2024
4:04 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/24/2024
3:15 PM | Janux Therapeutics (Issuer)
Lichter Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
4:59 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
4:38 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
4:39 PM | Janux Therapeutics (Subject)
Paradigm Biocapital Advisors LP (Filed by)
| Form SC 13G | |
10/23/2024
4:07 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
3:36 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
3:20 PM | Janux Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund II, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
3:16 PM | Avalon Ventures XI, L.P. (Filed by)
Janux Therapeutics (Subject)
| Form SC 13D/A | |
10/22/2024
3:17 PM | Janux Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
10/21/2024
3:43 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024
3:25 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024
12:39 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
5:51 PM | Avalon BioVentures I, LP (Reporting)
Avalon BioVentures SPV I, L.P. (Reporting)
Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Issuer)
Lichter Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2024
3:57 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Your chance to get on the next “60-Second Trade” (Ad) Ever heard of the “60-Second Trade”?
It’s a unique cash flow strategy that lets regular traders target anywhere from $100 to a couple of thousand in extra cash flow in as little as 7 days…
In on Monday, out on Friday! Just head over here! |
10/18/2024
3:39 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
3:48 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024
4:06 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024
3:24 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2024
3:18 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
5:14 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
4:35 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
4:28 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
4:25 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
4:17 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/16/2024
4:10 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024
7:49 PM | Avalon BioVentures I, LP (Reporting)
Avalon BioVentures SPV I, L.P. (Reporting)
Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Issuer)
Lichter Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:29 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/30/2024
4:34 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024
6:30 PM | Campbell David Alan (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
6:31 PM | DiRaimondo Thomas (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
6:32 PM | Janux Therapeutics (Issuer)
Meyer Andrew Hollman (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
5:31 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024
4:05 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024
3:51 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024
3:51 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024
3:54 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024
3:18 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024
3:01 PM | Janux Therapeutics (Subject)
Meyer Andrew Hollman (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2024
3:05 PM | Campbell David Alan (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/26/2024
4:57 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/26/2024
4:35 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/26/2024
4:13 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/16/2024
8:35 PM | Janux Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
09/16/2024
8:41 PM | Avalon Ventures XI, L.P. (Filed by)
Janux Therapeutics (Subject)
| Form SC 13D/A | |
09/13/2024
4:01 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
8:18 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
7:54 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
8:07 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
7:42 PM | Avalon BioVentures I, LP (Reporting)
Avalon BioVentures SPV I, L.P. (Reporting)
Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Issuer)
Lichter Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
5:23 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:51 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144/A | |
09/11/2024
10:20 AM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144/A | |
09/10/2024
5:26 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
5:32 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
5:22 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
4:51 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
4:02 PM | Avalon BioVentures I, LP (Reporting)
Avalon BioVentures SPV I, L.P. (Reporting)
Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Issuer)
Lichter Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
3:13 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
5:03 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
5:09 PM | Janux Therapeutics (Subject)
Lichter Jay (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
2:35 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144/A | |
09/09/2024
1:28 PM | Janux Therapeutics (Subject)
Reardon Tighe (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2024
6:11 PM | Avalon Ventures XI, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2024
6:14 PM | Avalon BioVentures SPV I, L.P. (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Could This Tiny Device Help You Make an Extra $30k a Year? (Ad) I believe it’s going to power Elon Musk’s next AI revolution…
A revolution he believes will be worth more than $9 trillion.
That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED. Click here to see the details because I believe a lot of people will get rich. |
09/06/2024
6:17 PM | Avalon BioVentures I, LP (Reporting)
Janux Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024
6:06 PM | Dobek Maria (Reporting)
Janux Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/07/2024
3:20 PM | Janux Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
3:28 PM | Janux Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/24/2024
7:00 PM | Hernday Natasha (Reporting)
Janux Therapeutics (Issuer)
| Form 4/A | |
07/24/2024
7:00 PM | DOBMEIER ERIC (Reporting)
Janux Therapeutics (Issuer)
| Form 4/A | |
07/22/2024
7:01 PM | Hernday Natasha (Reporting)
Janux Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/22/2024
7:01 PM | DOBMEIER ERIC (Reporting)
Janux Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/22/2024
7:03 PM | Hernday Natasha (Reporting)
Janux Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
